Melanocortin receptor ligands appear in pigmentation and sexual-desire research histories. Where an approved product exists (e.g. bremelanotide labelling), use it as regulatory context — not as a template for research-chemical self-protocols.
EXPLAINER
Class explainer — melanocortin peptides
Research & laboratory use only
This article supports qualified researchers. It is not medical advice and must not be used to plan human or veterinary administration.
Primary literature
- PT-141: a melanocortin agonist for the treatment of sexual dysfunctionAnnals of the New York Academy of Sciences (2003)
- VYLEESI (bremelanotide) — FDA prescribing informationDrugs@FDA (2019)
Research updates
New batches and their COAs, plus documentation and handling guides. No hype, unsubscribe any time.